跳转至内容
Merck
CN
  • Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.

Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.

European journal of medicinal chemistry (2009-05-05)
Elena Dreassi, Alessandra Tania Zizzari, Federico Falchi, Silvia Schenone, Annalisa Santucci, Giovanni Maga, Maurizio Botta
摘要

A library of 23 pyrazolo-pyrimidine compounds Src tyrosine kinase (TK) inhibitors, that reduced proliferation of a human osteogenic sarcoma cell line, was taken to investigate lack of correlation between inhibition of cellular viability (CV%) and enzymatic inhibition constants (K(i) Src). With the aim of understanding this behaviour, we focused on physico-chemical parameters which characterize partition coefficient and diffusion through membrane. Parallel artificial membrane permeability assay (PAMPA) has been frequently used for the evaluation of in vitro permeability of new chemical entities and, in this paper, a new approach for determining permeability of low soluble compounds was obtained. Goodness of PAMPA methodology was confirmed by logK(w) and computational approaches, by VolSurf, Cerius(2) and QikProp software programs. The results suggest that the lipophilicity and passive diffusion across the membranes do not significantly influence the activity of the compounds. This trend can be explained by a different target for some of the compounds in our set. In fact some compounds resulted also to be active toward Abl enzyme, another cytoplasmatic TK.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
酮洛芬, ≥98% (TLC)
Supelco
华法林, PESTANAL®, analytical standard
Supelco
华法林, analytical standard
Sigma-Aldrich
咖啡因, BioXtra
Sigma-Aldrich
卡马西平, meets USP testing specifications
Sigma-Aldrich
酮洛芬, meets USP testing specifications